Alex Davis has represented both investment banks and issuers on capital markets and corporate transactions, including initial public offerings, other equity offerings, convertible debt offerings and acquisition financings. Alex also advises public companies with respect to general corporate and securities matters, including Exchange Act reporting obligations and corporate governance issues.

Download full bio 

Experience

  • Lulu’s – $92 Million IPO 

  • Rani Therapeutics – $73 Million IPO 

  • Janux Therapeutics – $194 Million IPO 

  • Day One Biopharmaceuticals – $184 Million IPO 

  • Archer to Combine With SPAC Atlas Crest Investment 

  • View all

Education

  • Columbia Law School
    JD, Harlan Fiske Stone Scholar, 2017

  • San Diego State University
    BS, Finance
    magna cum laude, 2014


Admissions & Credentials

California

Memberships

  • State Bar of California

  • San Diego County Bar Association